IL17A and lung cancer: Actually, IL-17 is overexpressed in a subset of lung cancer patients, it has been considered as an important cytokine in cancer promotion, and was reported to inhibit antitumor immune responses (71); plus, IL17 inflammatory phenotype could be caused by lower airway dysbiosis (67).